Here is what you need to know on Tuesday, October 13:
Shrugging-off the Wall Street tech rally, the market mood remained tepid so far this Tuesday, in the face of skepticism over a likelihood of a US fiscal stimulus deal to be reached soon. Further, news that the UK pharma giant, Johnson and Johnson, paused its COVID-19 vaccine trial due to an unexplained illness also powered the risk-off flows.
The Asian stocks traded mostly mixed while the US stock futures slipped on the discouraging vaccine news, which put a fresh bid under the safe-haven US dollar across its main competitors.
EUR/USD remained pressured around 1.1800 amid vaccine news and re-imposition of stricter restrictions in Germany, Spain and France to contain the coronavirus second-wave. New infections in Germany once again top 4000 on Tuesday.
GBP/USD consolidated the early drop around 1.3050 ahead of the UK jobs report. On Monday, BOE Governor Andrew Bailey downplayed expectations of negative interests while UK PM Boris Johnson announced a three-tier system of restrictions for England with the Liverpool region under strictest tier 3. The cable hit five-week highs of 1.3083 despite the looming no-deal Brexit risks.
Gold held the lower ground around the $1915, looking to extend the correction from two-week highs of $1930.
WTI rebounded to test $40 after hitting a five-day low at $39 amid the return of oversupply concerns.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.